...Other) Broad Institute of MIT and Harvard Chiesi Farmaceutici S.p.A. Columbia University Dynavax Technologies Corp. InBios International Inc. Regeneron Santhera Pharmaceuticals Holding AG Syntonix Pharmaceuticals Inc. TransCelerate...

...BioCentury, Aug. 10, 2015). The original deal was between Syntonix Pharmaceuticals Inc. and Biovitrum AB. Biogen acquired Syntonix...

...see BioCentury, Aug. 10). The original deal was between Syntonix Pharmaceuticals Inc. and Biovitrum AB. Biogen acquired Syntonix...

...see BioCentury, June 29). The original deal was between Syntonix Pharmaceuticals Inc. and Biovitrum AB. Biogen acquired Syntonix...
...in 2007, and Biovitrum acquired Swedish Orphan International AB in 2009 and changed its name. Syntonix Pharmaceuticals Inc....

...Nov. 10, 2014). The original deal was between Syntonix Pharmaceuticals Inc. and Biovitrum AB. Biogen Idec acquired Syntonix...
...in 2007, and Biovitrum acquired Swedish Orphan International AB in 2009 and changed its name. Syntonix Pharmaceuticals Inc....

...between Swedish Orphan and Biogen Idec was between Biovitrum AB and Syntonix Pharmaceuticals Inc. Biogen Idec acquired Syntonix...
...products using XTEN to treat hemophilia (see BioCentury, April 18, 2011 & April 28, 2014). Syntonix Pharmaceuticals Inc....

...for Alprolix under an amended 2006 deal. The original deal was between Biovitrum AB and Syntonix Pharmaceuticals Inc....

...between Swedish Orphan and Biogen Idec was between Biovitrum AB and Syntonix Pharmaceuticals Inc. Biogen Idec acquired Syntonix...

...for Alprolix under an amended 2006 deal. The original deal was between Biovitrum AB and Syntonix Pharmaceuticals Inc....

...for Alprolix under an amended 2006 deal. The original deal was between Biovitrum AB and Syntonix Pharmaceuticals Inc....